Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00111176 · ClinicalTrials.gov registry record · NA

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

A NA study of Thoracic Aortic Aneurysm, sponsored by Cook Group Incorporated.

Completed
Registry status
NA
Development phase
260
Enrollment target
20
Study locations

NCT00111176: Completed NA study of Thoracic Aortic Aneurysm, sponsored by Cook Group Incorporated.

NCT00111176 is a NA study of Thoracic Aortic Aneurysm that has completed, run by Cook Group Incorporated. The registered enrollment target is 260 participants, below the 875-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00111176, a NA study of Thoracic Aortic Aneurysm, has completed, sponsored by Cook Group Incorporated.

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target
20
Study locations

Study Summary

The STARZ-TX2 trial (Study of Thoracic Aortic Aneurysm Repair with the Zenith TX2(R) TAA \[Thoracic Aortic Aneurysm\] Endovascular Graft) is a clinical trial approved by the United States Food and Drug Administration (FDA) to study the safety and effectiveness of the Zenith TX2 TAA Endovascular Graft in the treatment of thoracic aortic aneurysms / ulcers.

Conditions Studied

Interventions

  • PROCEDURE Surgical
  • DEVICE Endovascular repair

Study Locations (20)

Arizona

  • Banner Desert Medical Center - Mesa
  • Arizona Heart Institute - Phoenix

California

  • University of California, San Francisco - San Francisco
  • Stanford University Hospital and Clinics - Stanford

Florida

  • University of Florida - Gainesville
  • Mayo Clinic - Jacksonville

Maryland

  • University of Maryland Medical Center - Baltimore
  • Union Memorial Hospital - Baltimore

Colorado

  • Swedish Medical Center - Englewood

District of Columbia

  • Washington Hospital Center - Washington D.C.

Georgia

  • Emory University - Atlanta

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2004-03
Est. Completion 2013-05
Phase NA
Cook Group Incorporated

31 total trials

What the finished NCT00111176 record still lists

NCT00111176 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 875-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Thoracic Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Surgical is the first listed.

NCT00111176 names 20 study sites across 16 states, led by Arizona, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00111176 about?

NCT00111176 is a clinical study titled "STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft". The STARZ-TX2 trial (Study of Thoracic Aortic Aneurysm Repair with the Zenith TX2(R) TAA \[Thoracic Aortic Aneurysm\] Endovascular Graft) is a clinical trial approved by the United States Food and Drug Administration (FDA) to study the safety and effectiveness of the Zenith TX2 TAA Endovascular Graf...

What is the current status of trial NCT00111176?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2004-03. Estimated completion is 2013-05.

What conditions does trial NCT00111176 study?

This clinical trial studies the following conditions: Thoracic Aortic Aneurysm.

What interventions are being tested in trial NCT00111176?

The interventions under investigation include: Surgical (PROCEDURE), Endovascular repair (DEVICE).

Who is sponsoring clinical trial NCT00111176?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00111176 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02283996 · 260 participants · Phase 4

    Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

  • NCT03276793 · 260 participants · NA

    Brain Connectivity in Depression

  • NCT03407469 · 260 participants

    Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

  • NCT03713125 · 260 participants · NA

    Executive Function in Early Childhood

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00111176, the US trial registry maintained by the National Library of Medicine. NCT00111176 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.